01 / Contract Profile
75N93018C00024 Federal Contract Award
Agency code 7529
TO ADVANCE THE NOVEL H7-ADVAX PANDEMIC VACCINE CANDIDATES THROUGH TO PHASE 1 CLINICAL TRIALS THROUGH DELIVERY TO THE GOVERNMENT OF: PRELIMINARY DATA REGARDING ADJUVANT FOR FORMULATIONS (BASE REQUIREMENT/CLIN 001); MANUFACTURED PRODUCT (RELEASE) FOR S
02 / Contract Size and Status
What is the recorded size and timing of this contract?
03 / Spending Trend
75N93018C00024 contract spending by fiscal year
Annual net obligations across the complete period available for this agency and PIID, from the first recorded fiscal year through the latest contract action.
Latest fiscal year obligations-$535.7K
FY 2025Net obligationsComplete recorded range
| Fiscal year | Net obligations | Actions | Change |
|---|---|---|---|
| FY 2018 | $2.84M | 1 | — |
| FY 2019 | $0 | 1 | −100.0% |
| FY 2020 | $3.53M | 2 | — |
| FY 2021 | $0 | 1 | −100.0% |
| FY 2022 | $0 | 1 | — |
| FY 2023 | $0 | 1 | — |
| FY 2025 | -$535.7K | 1 | — |
04 / Federal Buyer
Which organization manages this contract?
| Department | Contracting agency | Contracting office |
|---|---|---|
| HEALTH AND HUMAN SERVICES, DEPARTMENT OF | NATIONAL INSTITUTES OF HEALTH | NATIONAL INSTITUTES OF HEALTH NIAID |
05 / Contractor
Who holds this federal contract?
VAXINE PTY LTD
UEI Z9AUC2SNX5A4 · CAGE Z0ED5
06 / NAICS Industries
Which industries classify this contract?
| Code | Description | Obligations | Actions | Share |
|---|---|---|---|---|
| 541714 | RESEARCH AND DEVELOPMENT IN BIOTECHNOLOGY (EXCEPT NANOBIOTECHNOLOGY) | $5.83M | 8 | 100.0% |
07 / Products and Services
What products or services were purchased?
| Code | Description | Obligations | Actions | Share |
|---|---|---|---|---|
| AN12 | HEALTH R&D SERVICES; HEALTH CARE SERVICES; APPLIED RESEARCH | $5.83M | 8 | 100.0% |
08 / Place of Performance
Where is the work recorded?
AUSTRALIA
ZIP 5042
09 / Contract Actions
What modifications and obligations were recorded?
| Signed date | Modification | Obligation | Contracting office | NAICS | PSC |
|---|---|---|---|---|---|
| Sep 23, 2025 | P00007 | -$535.7K | NATIONAL INSTITUTES OF HEALTH NIAIDOffice code 75N930 | 541714 | AN12 |
| Jan 6, 2023 | P00006 | $0 | NATIONAL INSTITUTES OF HEALTH NIAIDOffice code 75N930 | 541714 | AN12 |
| Aug 11, 2022 | P00005 | $0 | NATIONAL INSTITUTES OF HEALTH NIAIDOffice code 75N930 | 541714 | AN12 |
| Aug 10, 2021 | P00004 | $0 | NATIONAL INSTITUTES OF HEALTH NIAIDOffice code 75N930 | 541714 | AN12 |
| Aug 12, 2020 | P00003 | $3.53M | NATIONAL INSTITUTES OF HEALTH NIAIDOffice code 75N930 | 541714 | AN12 |
| Mar 13, 2020 | P00002 | $0 | NATIONAL INSTITUTES OF HEALTH NIAIDOffice code 75N930 | 541714 | AN12 |
| Aug 28, 2019 | P00001 | $0 | NATIONAL INSTITUTES OF HEALTH NIAIDOffice code 75N930 | 541714 | AN12 |
| Sep 20, 2018 | Base action | $2.84M | NATIONAL INSTITUTES OF HEALTH NIAIDOffice code 75N930 | 541714 | AN12 |
10 / Reading the Contract
How should this award record be interpreted?
Read the PIID as a transaction history, not as a single purchase price. Net obligations combine the base action with later increases, reductions, corrections, and deobligations recorded under the same contract.
Verify the buyer
Agency and office identify who manages the procurement relationship.
Follow modifications
Each action can change funding, scope, dates, or administrative terms.
Compare the market
Use NAICS, PSC, and the contractor profile to identify related buyers and competitors.